Evommune, Inc. (EVMN)
25.61
-0.39
(-1.50%)
USD |
NYSE |
Mar 02, 16:00
26.07
+0.46
(+1.80%)
Pre-Market: 20:00
Evommune Profit Margin (Quarterly) : -124.8% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 21.74% |
| Moderna, Inc. | -121.8% |
| BillionToOne, Inc. | 1.80% |
| Nektar Therapeutics | -301.3% |
| CorMedix, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -71.60% |
| Return on Invested Capital | -86.53% |
| Gross Profit Margin (Quarterly) | 96.89% |
| Operating Margin (Quarterly) | -133.3% |
| Return on Net Operating Assets | -4.71K% |